Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?
Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...
Keeping blood pressure under control is critical. There’s a new option for tough cases
About half of U.S. adults have high blood pressure and too few have it under control. Now some patients who've tried ...
Newser on MSN6h
New Painkiller May Be 'Landmark Development'
The FDA is expected to grant approval to a new pain medication with big potential—mainly because it's a non-opioid and is ...
pharmaphorum1d
FDA approves flurry of drugs ahead of holiday season
It's the second drug in the TFPI ... given accelerated approval by the FDA as first-line therapy for BRAF V600E-mutated metastatic colorectal cancer, one of a series of new cancer indications ...
pharmaphorum1d
FDA changes its mind and approves Takeda’s Eohilia
In its second attempt, Takeda has secured FDA approval for Eohilia ... oral suspension formulation of the well-established steroid drug budesonide, for people 11 years and older with EoE after ...
Hosted on MSN15h
Are These Red Dye 3 Foods on Your Grocery List? What to Know About FDA Ban
Like all color additives used in U.S. foods, Red Dye No. 3 underwent safety evaluations before receiving FDA approval in the ...